Brain cannabinoid receptor 2: expression, function and modulation.
De-Jie Chen, Ming Gao, Fen-Fei Gao, Quan-Xi Su, Jie Wu
Acta pharmacologica Sinica March 2017 DOI: 10.1038/aps.2016.149 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | The authors argue that CB2 receptors are expressed and functional in specific brain areas, challenging the traditional view that they are confined to peripheral immune cells. They cite evidence that activating ventral tegmental area CB2 receptors reduces neuronal excitability and cocaine-seeking behavior in mice, and that CB2 receptors modulate hippocampal CA3 excitability and network synchronization. |
Abstract
Cannabis sativa (marijuana) is a fibrous flowering plant that produces an abundant variety of molecules, some with psychoactive effects. At least 4% of the world's adult population uses cannabis annually, making it one of the most frequently used illicit drugs in the world. The psychoactive effects of cannabis are mediated primarily through cannabinoid receptor (CBR) subtypes. The prevailing view is that CB1Rs are mainly expressed in the central neurons, whereas CB2Rs are predominantly expressed in peripheral immune cells. However, this traditional view has been challenged by emerging strong evidence that shows CB2Rs are moderately expressed and function in specific brain areas. New evidence has demonstrated that brain CB2Rs modulate animal drug-seeking behaviors, suggesting that these receptors may exist in brain regions that regulate drug addiction. Recently, we further confirmed that functional CB2Rs are expressed in mouse ventral tegmental area (VTA) dopamine (DA) neurons and that the activation of VTA CB2Rs reduces neuronal excitability and cocaine-seeking behavior. In addition, CB2R-mediated modulation of hippocampal CA3 neuronal excitability and network synchronization has been reported. Here, we briefly summarize recent lines of evidence showing how CB2Rs modulate function and pathophysiology in the CNS.
Citations in the library
Cited by 7
- Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data? Pharmacology & Therapeutics February 1, 2018
- Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research Frontiers in Pharmacology June 21, 2017
- Analytical Challenges and Health Implications of "Tusi" (2C): A Critical Review. Critical Reviews in Analytical Chemistry September 12, 2025
- Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis International Journal of Molecular Sciences April 19, 2023
- A relação entre o uso da cannabis e o despertar de psicoses Revista Brasileira Multidisciplinar 2020
and 2 more in the library